Status:

COMPLETED

METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial)

Lead Sponsor:

Instituto de Cardiologia do Rio Grande do Sul

Conditions:

Heart Failure

Myocardial Ischemia

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

PHASE3

Brief Summary

The aim of the study is to evaluate the efficacy of methotrexate to improve physical capacity in patients with symptomatic ischemic heart failure.

Detailed Description

Recent studies have showed the importance of proinflammatory mediators in the heart failure. However, there is a lack of benefit of therapies that tried to neutralize these mediators. Methotrexate ha...

Eligibility Criteria

Inclusion

  • Heart failure functional class measured using the New York Heart Association classification class II, III or IV
  • Left ventricular fraction \<0.45 at the ventriculography
  • Angiographic coronary lesions higher than 50% or coronary lesion revascularized (coronary artery bypass or percutaneous transluminal coronary angioplasty)

Exclusion

  • Myocardial infarction in the past four months
  • Coronary artery bypass or percutaneous transluminal coronary angioplasty in the past four months
  • Left ventricular disfunction diagnosed during a acute coronary syndrome
  • Those who require revascularization in the following 12 weeks
  • Hepatic disease (ALT and AST higher than the upper limit of the reference value)
  • Renal failure (plasma creatinine higher than 2.0mg/dl)
  • Alcoholism (20 doses per week or more)
  • Illegal drug use
  • Rheumatoid arthritis or other inflammatory diseases
  • Infectious disease
  • Neoplasm
  • Anemia (hematocrit lower than 30%)
  • Currently on any anti-inflammatory drugs
  • Difficulty in walking
  • Unable to understand/complete the 36-item Short Form health survey (SF-36)
  • Those who do not give informed consent

Key Trial Info

Start Date :

December 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2008

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00759811

Start Date

December 1 2007

End Date

November 1 2008

Last Update

May 8 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Instituto de Cardiologia do Rio Grande do Sul / Fundação Universitária de Cardiologia

Porto Alegre, Rio Grande do Sul, Brazil, 90620001